Apimeds Pharmaceuticals US, Inc
5.0M
$3.77M
0.00
$-551.47
No price alerts set. Add an alert to get notified!
0.00
0.00
$-551.47
-3.91%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ANTX
AN2 Therapeutics, Inc.
|
$4.69 | -3.30% | -4.03 | $128.52M | 0.00 |
|
IGC
IGC Pharma, Inc.
|
$0.32 | 0.37% | -5.73 | $31.83M | 0.02 |
|
MIRA
MIRA Pharmaceuticals, Inc.
|
$1.02 | -0.97% | -0.76 | $42.86M | 0.00 |
|
MLSS
Milestone Scientific Inc.
|
$0.40 | 12.14% | -5.71 | $32.02M | 0.36 |
|
MYO
Myomo, Inc.
|
$0.88 | 1.69% | -2.36 | $33.79M | 1.70 |
|
NXTC
NextCure, Inc.
|
$9.32 | 4.48% | -0.59 | $24.98M | 0.15 |
|
POCI
Precision Optics Corporation, Inc.
|
$4.60 | 8.75% | -5.13 | $35.57M | 0.47 |
|
QTTB
Q32 Bio Inc.
|
$5.14 | 1.98% | 1.77 | $63.22M | 0.24 |
|
SCYX
SCYNEXIS, Inc.
|
$0.94 | -4.20% | -4.77 | $42.13M | 0.04 |
|
TLPH
Talphera, Inc.
|
$0.90 | 1.39% | -2.68 | $18.52M | 0.38 |
* Peer stocks are selected based on market capitalization and sector
$40.31
$1.61
$0.00
0.00%
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
